We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals
ANIP

157 hedge funds and large institutions have $379M invested in ANI Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 58 increasing their positions, 47 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more ownership

Funds ownership: 0% → 54% (+54%)

23% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 47

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less capital invested

Capital invested by funds: $399M → $379M (-$19.5M)

8% less funds holding

Funds holding: 170 → 157 (-13)

33% less call options, than puts

Call options by funds: $6.65M | Put options by funds: $9.9M

40% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 25

Holders
157
Holders Change
-13
Holders Change %
-7.65%
% of All Funds
3.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
58
Reduced
47
Closed
25
Calls
$6.65M
Puts
$9.9M
Net Calls
-$3.25M
Net Calls Change
-$3.46M

Top Buyers

1
PA
Perceptive Advisors
New York
+$15.6M
2
GT
Glenmede Trust
Pennsylvania
+$15.1M
3
BFA
BlackRock Fund Advisors
California
+$4.65M
4
Bank of America
Bank of America
North Carolina
+$4.12M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.66M

Top Sellers

1
CCM
Consonance Capital Management
New York
-$9.88M
2
CM
Castleark Management
Illinois
-$6.68M
3
SGAM
Smith Group Asset Management
Texas
-$3.96M
4
BIM
Bogle Investment Management
Massachusetts
-$3.7M
5
MCM
McKinley Capital Management
Alaska
-$3.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Creative Planning
126
Creative Planning
Kansas
$28K -$734 -12 -3%
SEI Investments
127
SEI Investments
Pennsylvania
$25K +$7.21K +118 +38%
LIA
128
LS Investment Advisors
Michigan
$20K – – –
FANJ
129
Financial Architects (New Jersey)
New Jersey
$17K – – –
SWA
130
Sutton Wealth Advisors
Florida
$14.4K – – –
Zurich Cantonal Bank
131
Zurich Cantonal Bank
Switzerland
$14K – – –
LWM
132
LBA Wealth Management
Florida
$8K -$12.2K -200 -62%
MFS
133
MSI Financial Services
Massachusetts
$8K -$7.46K -122 -47%
FPFS
134
First Personal Financial Services
North Carolina
$8K +$6.24K +102 +443%
YWP
135
YorkBridge Wealth Partners
New York
$8K +$7.83K +128 New
IA
136
IFP Advisors
Florida
$7K – – –
Northwestern Mutual Wealth Management
137
Northwestern Mutual Wealth Management
Wisconsin
$7K +$6.91K +113 New
BFEC
138
Benjamin F. Edwards & Company
Missouri
$6K – – –
FMII
139
Farmers & Merchants Investments Inc
Nebraska
$6K – – –
Loomis, Sayles & Company
140
Loomis, Sayles & Company
Massachusetts
$6K – – –
TRCT
141
Tower Research Capital (TRC)
New York
$5K -$45.2K -739 -90%
AIM
142
Advantage Investment Management
Iowa
$4K – – –
GAM
143
Gemmer Asset Management
California
$3K +$489 +8 +19%
VCM
144
Versant Capital Management
Arizona
$3K +$1.59K +26 +76%
GWM
145
Geneos Wealth Management
Colorado
$2K – – –
HMS
146
Hanseatic Management Services
New Mexico
$2K – – –
BTIS
147
BB&T Investment Services
North Carolina
$2K +$2.45K +40 New
MTIP
148
Magee Thomson Investment Partners
California
$1K – – –
TWA
149
TCI Wealth Advisors
Arizona
$1K – – –
SFS
150
Sowell Financial Services
Arkansas
$1K +$489 +8 New
4 5
6
7 8

ANIP Hedge Fund Activity: Q4 2016 in Review

157 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q4 2016, worth a combined $379M — down 4.9% from $399M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of ANIP and 15 opened new positions — a net loss of 10 holders — while 47 trimmed existing stakes and 58 added.

The largest buyer was Perceptive Advisors, adding an estimated $15.6M. The largest seller was Consonance Capital Management, cutting an estimated $9.88M.

  • 157 institutional investors held ANI Pharmaceuticals (ANIP) as of Q4 2016, down from 170 in Q3 2016.
  • Funds reported $379M of ANI Pharmaceuticals stock for Q4 2016, down 4.9% quarter-over-quarter.
  • 15 funds opened new ANI Pharmaceuticals positions in Q4 2016 and 25 closed out, a net change of -10 holders.
  • The largest ANI Pharmaceuticals buyer in Q4 2016 was Perceptive Advisors, an estimated $15.6M added.
  • The largest ANI Pharmaceuticals seller in Q4 2016 was Consonance Capital Management, an estimated $9.88M sold.

Based on aggregated 13F filings for Q4 2016.